1816. Deputy Ken O'Flynn asked the Minister for Health whether any formal policy exists governing the sequencing of assessment where a minor presenting with gender-related distress also presents with suspected or diagnosed autism spectrum disorder, ADHD, trauma-related conditions, severe mental health difficulties, or complex safeguarding concerns; and if they will provide details of such policy or guidance. [41673/2…
1817. Deputy Ken O'Flynn asked the Minister for Health whether the Consultant Applications Advisory Committee application submitted in December 2019 in relation to the proposed consultant child and adolescent psychiatry post under the National Gender Service Model of Care 2018 was approved in full by the CAAC; and whether the references to WPATH Standards of Care and Endocrine Society guidelines formed part of the ma…
1818. Deputy Ken O'Flynn asked the Minister for Health whether any written evidential review, literature review, clinical governance paper, risk assessment, or safety assessment was prepared by the HSE, the Department, the National Clinical Programme, or any associated governance structure regarding reliance upon WPATH Standards of Care within the National Gender Service Model of Care 2018 or associated consultant po…
1819. Deputy Ken O'Flynn asked the Minister for Health to identify the specific HSE national clinical governance structure, committee, officeholder, or decision-making body responsible for approving or overseeing the inclusion of WPATH Standards of Care references within the 2019 CAAC application relating to the proposed consultant child and adolescent psychiatry post for specialist gender healthcare services. [41686…
1820. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or Department conducted any review, reassessment, or governance evaluation following the publication of the Cass Review in the United Kingdom insofar as it related to the evidential basis underpinning the National Gender Service Model of Care 2018. [41687/26]
1821. Deputy Ken O'Flynn asked the Minister for Health whether documentary records exist including minutes, memoranda, briefing papers, internal correspondence, emails, governance submissions, or evidential assessments concerning the inclusion of WPATH Standards of Care references within the 2019 CAAC application; and whether such records will be retained under HSE records management and governance procedures. [41688…
1822. Deputy Ken O'Flynn asked the Minister for Health whether any concerns were recorded during the recruitment campaigns undertaken for the proposed consultant child and adolescent psychiatry post regarding the evidential basis, governance structure, clinical remit, or sustainability of the proposed service model. [41689/26]
1824. Deputy Ken O'Flynn asked the Minister for Health the number of nurses, doctors, and health and social care professionals recruited internationally by the HSE in each year from 2020 to 2026, broken down by profession and country of origin. [41691/26]
1825. Deputy Ken O'Flynn asked the Minister for Health the estimated annual attrition rate within the HSE workforce for nurses, doctors, and health and social care professionals in each year from 2020 to 2026. [41692/26]
1826. Deputy Ken O'Flynn asked the Minister for Health the number of Irish-trained healthcare professionals who emigrated or took up employment outside the State in each year since 2020, insofar as figures are available. [41693/26]
1827. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure incurred by the HSE on international recruitment campaigns, relocation packages, recruitment agencies, and associated supports from 2020 to 2026. [41694/26]
1828. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of long-term workforce sustainability should international recruitment levels decline. [41695/26]
1829. Deputy Ken O'Flynn asked the Minister for Health the current vacancy rate across nursing, medical and health and social care professional grades by Health Region. [41696/26]
1830. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has set any targets to reduce reliance on international recruitment over the next five years. [41697/26]
1831. Deputy Ken O'Flynn asked the Minister for Health whether any national guidance exists governing how referrals deemed ineligible for SCAN services are recorded, categorised, or redirected within the mental health system. [41698/26]
1832. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any mechanism to track outcomes for persons referred to SCAN services but redirected to alternative pathways. [41699/26]
1833. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken regarding regional variation in SCAN eligibility decisions or referral acceptance practices. [41700/26]
1834. Deputy Ken O'Flynn asked the Minister for Health whether the forthcoming SCAN KPI framework will include data relating to rejected, redirected, or ineligible referrals. [41701/26]
1835. Deputy Ken O'Flynn asked the Minister for Health whether consideration is being given to establishing a nationally standardised dataset for referrals not accepted into SCAN services. [41702/26]
1836. Deputy Ken O'Flynn asked the Minister for Health whether any adverse incident review process exists where a person deemed ineligible for SCAN services subsequently presents in crisis, self-harms, or requires emergency intervention. [41703/26]
1837. Deputy Ken O'Flynn asked the Minister for Health whether SCAN services currently operate under nationally standardised eligibility criteria and whether these criteria are publicly available. [41704/26]
1838. Deputy Ken O'Flynn asked the Minister for Health whether any audit has been undertaken into onward referral pathways for persons not accepted into SCAN services. [41705/26]
1839. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has undertaken any modelling of the projected annual eligible population for reimbursement of tirzepatide or semaglutide for obesity treatment over the next five years. [41712/26]
1840. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the potential annual Exchequer cost associated with reimbursement of obesity pharmacotherapies under current licensing criteria. [41713/26]
1841. Deputy Ken O'Flynn asked the Minister for Health whether any national eligibility framework, prioritisation framework, or phased access model is under development for obesity pharmacotherapy reimbursement. [41714/26]